| Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of … N Soliman, S Haroutounian, AG Hohmann, E Krane, J Liao, M Macleod, ... Pain 162, S26-S44, 2021 | 101 | 2021 |
| Trace amine-associated receptor 1 modulates the locomotor and sensitization effects of nicotine I Sukhanov, M Dorofeikova, A Dolgorukova, A Dorotenko, RR Gainetdinov Frontiers in pharmacology 9, 341972, 2018 | 30 | 2018 |
| Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats I Sukhanov, A Dorotenko, A Dolgorukova, MC Hoener, RR Gainetdinov, ... Neuropharmacology 144, 184-192, 2019 | 15 | 2019 |
| Differential effects of the Piezo1 agonist Yoda1 in the trigeminovascular system: An electrophysiological and intravital microscopy study in rats A Dolgorukova, JE Isaeva, E Verbitskaya, OA Lyubashina, RА Giniatullin, ... Experimental Neurology 339, 113634, 2021 | 12 | 2021 |
| The action of TAAR1 agonist RO5263397 on executive functions in rats A Dorotenko, M Tur, A Dolgorukova, N Bortnikov, IV Belozertseva, ... Cellular and Molecular Neurobiology 40 (2), 215-228, 2020 | 10 | 2020 |
| The influence of metoclopramide on trigeminovascular nociception: Possible anti-migraine mechanism of action A Dolgorukova, AV Osipchuk, AA Murzina, AY Sokolov Neuroscience 425, 123-133, 2020 | 8 | 2020 |
| Activation of trace amine-associated receptor 1 reduces schedule-induced polydipsia in rats A Dolgorukova, A Dorotenko, L Mus, RR Gainetdinov, I Sukhanov European Neuropsychopharmacology 27 (S4), 673-673, 2017 | 5 | 2017 |
| Possible approaches to CYP2C9-guided prescription of sulfonylureas in Russia A Mosikian, A Dolgorukova, A Zalevskaya Pharmacogenomics 17 (18), 2115-2126, 2016 | 4 | 2016 |
| P. 2.01 Metoclopramide inhibits trigemino-durovascular nociception: implication for migraine A Dolgorukova, I Vaganova, A Sokolov European Neuropsychopharmacology 29, S655, 2019 | 2 | 2019 |
| Evaluation of effects of the TAAR1 partial agonist RO5263397 on executive cognitive functions I Sukhanov, A Dorotenko, N Bortnikov, M Tur, A Dolgorukova, ... European Neuropsychopharmacology 29, S261-S262, 2019 | 2 | 2019 |
| Meta‐analysis of the effects of anti‐migraine therapeutics in the rat trigeminovascular nociception model as a tool for design optimization A Dolgorukova, E Protsenko, J Isaeva, V Gagloeva, E Verbitskaya, ... European Journal of Neuroscience 58 (1), 2339-2360, 2023 | 1 | 2023 |
| Meta-analysis of the effects of clinically-effective therapeutics in the preclinical migraine model as a tool for design optimisation A Dolgorukova, E Protsenko, J Isaeva, V Gagloeva, E Verbitskaya, ... bioRxiv, 2022.07. 05.498780, 2022 | 1 | 2022 |
| P. 432 Dural application of the Piezo1 agonist Yoda1 induces dilation of trigeminovascular system-related arteries in rats A Dolgorukova, JE Isaeva, OA Lyubashina, RА Giniatullin, AY Sokolov European Neuropsychopharmacology 40, S245-S246, 2020 | 1 | 2020 |
| P. 792 The facilitatory effect of the selective Piezo1 agonist Yoda1 on second-order trigeminovascular neurons in vivo A Dolgorukova, JE Isaeva, OA Lyubashina, E Verbitskaya, RА Giniatullin, ... European Neuropsychopharmacology 40, S448-S449, 2020 | 1 | 2020 |
| The trace amine-associated receptor 1 modulates nicotine behavioural effects I Sukhanov, A Dorotenko, A Dolgorukova, M Dorofeikova, RR Gainetdinov European Neuropsychopharmacology 27 (S4), 673-674, 2017 | 1 | 2017 |
| Bioequivalence study of generic nirmatrelvir in healthy volunteers RA Oseshnyuk, AG Nikiforova, AY Boroduleva, PD Sobolev, ... Pharmacy & Pharmacology-Farmatsiya I Farmakologiya, 62-71, 2023 | | 2023 |
| The implementation of transcranial Doppler ultrasonography for preclinical study of migraine A Dolgorukova, AV Potapenko, AA Murzina, OA Lyubashina, A Y. Sokolov Canadian Journal of Physiology and Pharmacology 100 (6), 553-561, 2022 | | 2022 |
| Olokizumab reduces the risks of death in hospitalized patients with moderate and severe COVID-19 EV Tavlueva, AE Markarov, MA Petrushin, AA Wiesel, GL Ignatova, ... Infectious Diseases: News, Opinions, Training, 8-18, 2022 | | 2022 |
| Characteristics of olokizumab pharmacokinetics in patients with novel coronavirus infection COVID-19 EV Tavlueva, EV Zernova, MP Kutepova, NE Kostina, VS Lesina, ... Pharmacy & Pharmacology 10 (5), 460-471, 2022 | | 2022 |
| No tolerance to anticompulsive activity of trace amine-associated receptor 1 agonist following repeated administration A Dorotenko, A Dolgorukova, K Antonova, E Efimova, RR Gainetdinov, ... European Neuropsychopharmacology 28, S38-S39, 2018 | | 2018 |
Ilya SukhanovFirst Pavlov State Medical Univercity of Saint PetersburgVerified email at iit.it
